Monte Rosa Therapeutics, Inc. (GLUE)
19.55
+0.65
(+3.44%)
USD |
NASDAQ |
Feb 06, 16:00
19.53
-0.02
(-0.10%)
After-Hours: 20:00
Monte Rosa Therapeutics EPS Diluted (Quarterly) : -0.3287 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 0.0558 |
| Pfizer Inc. | -0.2898 |
| CorMedix, Inc. | 1.259 |
| Zoetis, Inc. | 1.627 |
| Alumis, Inc. | -1.064 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -27.08M |
| Revenue (Quarterly) | 12.77M |
| Total Expenses (Quarterly) | 39.85M |
| Enterprise Value | 921.96M |
| Gross Profit Margin (Quarterly) | 83.59% |
| Profit Margin (Quarterly) | -212.1% |
| Earnings Yield | 1.56% |
| Operating Earnings Yield | 0.56% |
| Normalized Earnings Yield | 1.562 |